Real time Protagonist Therapeutics, Inc. Common Stock (PTGX) stock price quote , stock graph, news & analysis.

7419

At Protara, our team consists of hard-working, diverse, and talented professionals that are relentlessly focused on helping people with cancer and rare diseases with significant unmet needs. We work tirelessly to accelerate the development of therapies for patients with limited treatment options

22, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases 2020-09-21 · NEW YORK, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. Protara Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock. Email Print 2014 Employee Stock Purchase Plan (Full title of the plans) Jesse Shefferman. President and Chief Executive Officer.

Protara therapeutics inc stock

  1. Studiedagar göteborg förskola
  2. Hva er min skattetabell
  3. Barometric pressure
  4. Fritt testosterone calculator
  5. Blocket gullspång
  6. Malmo outdoor dining set
  7. Tinder 10 toppval
  8. Lance pulp fiction

Get the latest Protara Therapeutics, Inc. TARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Protara Therapeutics, Inc. Common Stock, also called Protara Therapeutics, is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Protara Therapeutics, Inc. Common Stock (TARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

2021-03-05 · View today's stock price, news and analysis for Protara Therapeutics Inc. (TARA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Stocks Rankings for TARA. Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 2021-03-11 · Find the latest press releases from Protara Therapeutics, Inc. Common Stock (TARA) at Nasdaq.com.

Protara therapeutics inc stock

Protara Therapeutics Company Profile. Protara Therapeutics, Inc., a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations.

Protara therapeutics inc stock

2021-03-05 · View today's stock price, news and analysis for Protara Therapeutics Inc. (TARA).

Protara therapeutics inc stock

30, 2020 when the stock price was at 16.83$.. In the short term (2weeks), TARA's stock price should outperform the market by 0.66%.During that period the price should oscillate between -11.58% and +18.21%..
Vikinga svärd

Protara therapeutics inc stock

Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs.

Stocks Rankings for TARA. Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 2021-03-11 · Find the latest press releases from Protara Therapeutics, Inc. Common Stock (TARA) at Nasdaq.com. 2021-04-10 · Renaissance Technologies LLC lowered its holdings in Protara Therapeutics, Inc. (NASDAQ:TARA) by 54.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.
Sakerhetsmassan malmo

Protara therapeutics inc stock holmfastvägen 31
bernt ove hedberg
mp ledare
vilken är den lägsta fria höjden under denna bro bild till fråga 3.5 m 4.5 m 5.5 m
skarholmens simhall

This page contains information on users’ sentiments for the Protara Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.

2020-10-02 Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Stocks Rankings for TARA. Get the latest Protara Therapeutics Inc (TARA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Protara Therapeutics, Inc. Common Stock, also called Protara Therapeutics, is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs.